Joshua M. Sharfstein
Joshua M. Sharfstein

Joshua M. Sharfstein, MD

  • Vice Dean for Public Health Practice and Community Engagement
  • Professor of the Practice

Departmental Affiliations

  • Health Policy and Management (Primary)
  • School of Medicine (Joint)

Center & Institute Affiliations

  • Center for Drug Safety and Effectiveness
  • Center for Population Health Information Technology (CPHIT)

Contact Information

615 N. Wolfe Street
Room W1033D
Baltimore, Maryland 21205

P:  443-424-8490



MD, Harvard Medical School, 1996


Dr. Sharfstein oversees the Office of Public Health Practice and Training, the General Preventive Medicine Residency and major practice activities, including collaboration with public health agencies. He also holds a faculty appointment in the Department of Health Policy and Management. Previously, he served as the Secretary of the Maryland Department of Health and Mental Hygiene, the Principal Deputy Commissioner of the U.S. Food and Drug Administration, as Commissioner of Health for Baltimore City, and as health policy advisor for Congressman Henry A. Waxman.

Honors and honors


Circle of Commendation Award, Consumer Product Safety Commission


Public Official of the Year, Governing Magazine


Alpha Omega Alpha, Boston University School of Medicine


Rose Seegal Award for Research, Community Service Award, Robert H. Ebert Prize in Primary Care, Harvard Medical School


Jay S. Drotman Memorial Award, American Public Health Association


Phi Beta Kappa, Thomas Temple Hoopes Prize, Frederick Sheldon Traveling Fellowship, Harvard College


I have written on a wide range of public health topics. Here are a few examples.

  • Sharfstein J. The strange career of population health. Milbank Quarterly 2014; 92: 640-643.

  • Rajkumar R, Patel A, Murphy K, Colmers JM, Blum JD, Conway PH, Sharfstein JM. Maryland's All-Payer Approach to Delivery-System Reform. New England Journal of Medicine 2014; 370(6) 493-5.

  • Olsen Y, Sharfstein J. Confronting the stigma of opioid use disorder—and its treatment. Journal of the American Medical Association 2014; 311: 1393-4.

  • Sharfstein JM. The FDA--a misunderstood agency. Journal of the American Medical Association 2011; 306:1250-1.

  • Sharfstein J and Sharfstein SS. Campaign contributions from the American Medical Political Action Committee to members of Congress: For or against the public health? New England Journal of Medicine.1994; 330: 32–37. Correction: 332:1450.